Know the Risks of Tianeptine

August 2025

Tianeptine is making headlines...based on recent warnings about risk of serious harm or death.

Tianeptine is approved in some Asian, European, and Latin American countries as an atypical antidepressant. It works by modulating glutamate...and it’s an opioid receptor agonist.

But it’s not approved in Canada for any use.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote